CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment
Author:
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology
Reference109 articles.
1. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability;Adhikari;Nat. Commun.,2018
2. Reverse phase protein microarrays;Baldelli,2017
3. A phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens;Bennouna;Invest. New Drugs,2011
4. The RIF1-PP1 axis controls abscission timing in human cells;Bhowmick;Curr. Biol.,2019
5. A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy;Bodoky;Invest. New Drugs,2012
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research;Cancers;2024-01-22
2. Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation;International Journal of Molecular Sciences;2023-04-21
3. VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer;Genes & Cancer;2023-03-10
4. Gemcitabine promotes autophagy and lysosomal function through ERK- and TFEB-dependent mechanisms;Cell Death Discovery;2023-02-06
5. Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage;2023-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3